Physician profile
Traci Schrag
NPI 1629726492
$7,265.09
in general payments reported to CMS, 2019-2025
47 companies · $2,072 in 2025
The $2,072 reported for 2025 was more than what 95% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,336 · 2023: $1,856 · 2024: $2,002 · 2025: $2,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,774 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,773.66 |
| Education | $155.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $817.18 | 2022-2025 | Tezspire, Fasenra, Airsupra |
| Regeneron Healthcare Solutions, INC. | $616.74 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $525.40 | 2022-2025 | Trelegy Ellipta, Nucala, Shingrix |
| United Therapeutics Corporation | $464.59 | 2022-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $450.73 | 2022-2024 | Yupelri |
| Pulmonx Corporation | $390.29 | 2022-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Baxter Healthcare | $370.96 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.00 | 2022-2025 | Jardiance, Jascayd, Cyltezo |
| Actelion Pharmaceuticals US, INC. | $296.37 | 2022-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $265.83 | 2022-2025 | Dificid, Zerbaxa, Recarbrio |
| Janssen Biotech, INC. | $231.26 | 2023-2025 | Tremfya, Stelara |
| Ardelyx, INC. | $222.04 | 2022-2025 | Ibsrela |
| Genzyme Corporation | $205.47 | 2023-2025 | |
| Amgen INC. | $170.32 | 2023-2025 | Tezspire, Repatha, Otezla |
| Insmed, INC. | $169.05 | 2024-2025 | Arikayce, Brinsupri |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traci Schrag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.